|
| US3995635 | 4 nov. 1974 | 7 déc. 1976 | Alza Corporation | Ocular insert |
| US4136173 | 31 janv. 1977 | 23 janv. 1979 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
| US4136177 | 31 janv. 1977 | 23 janv. 1979 | American Home Products Corp. | Xanthan gum therapeutic compositions |
| US4136178 | 31 janv. 1977 | 23 janv. 1979 | American Home Products Corp. | Locust bean gum therapeutic compositions |
| US4201210 | 28 nov. 1977 | 6 mai 1980 | The United States of America as represented by the Secretary of Agriculture | Veterinary ocular ring device for sustained drug release |
| US4304226 | 3 mars 1980 | 8 déc. 1981 | The Procter & Gamble Company | Vaginal contraceptive |
| US4959217 | 22 mai 1986 | 25 sept. 1990 | Syntex (U.S.A.) Inc. | Delayed/sustained release of macromolecules |
| US5270051 | 15 oct. 1991 | 14 déc. 1993 | | Enzyme-orthokeratology |
| US5378475 | 21 févr. 1991 | 3 janv. 1995 | University of Kentucky Research Foundation | Sustained release drug delivery devices |
| US5472436 | 26 juil. 1994 | 5 déc. 1995 | | Ocular appliance for delivering medication |
| US5626865 | 18 juil. 1994 | 6 mai 1997 | Advanced Corneal Systems, Inc. | Enzyme-orthokeratology |
| US5773019 | 27 sept. 1995 | 30 juin 1998 | The University of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| US5788957 | 12 sept. 1996 | 4 août 1998 | Advanced Corneal Systems, Inc. | Enzyme-orthokeratology |
| US5876438 | 3 mai 1996 | 2 mars 1999 | Houston Biotechnology Incorporated | Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract |
| US5902598 | 28 août 1997 | 11 mai 1999 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
| US6063116 | 27 juin 1997 | 16 mai 2000 | Medarex, Inc. | Modulation of cell proliferation and wound healing |
| US6132735 | 18 sept. 1997 | 17 oct. 2000 | ISTA Pharmaceutical, Inc. | Enzyme-orthokeratology |
| US6161544 | 28 janv. 1998 | 19 déc. 2000 | Keratoform, Inc. | Methods for accelerated orthokeratology |
| US6264971 | 4 nov. 1999 | 24 juil. 2001 | BTG International Limited | Ocular insert |
| US6303102 | 7 sept. 2000 | 16 oct. 2001 | | Cutaneously applied biodegradable tell-tale having controllable clearing time |
| US6331313 | 22 oct. 1999 | 18 déc. 2001 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
| US6375972 | 26 avr. 2000 | 23 avr. 2002 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| US6413245 | 4 oct. 2000 | 2 juil. 2002 | Alcon Universal Ltd. | Sub-tenon drug delivery |
| US6413540 | 12 sept. 2000 | 2 juil. 2002 | Alcon Universal Ltd. | Drug delivery device |
| US6416777 | 19 sept. 2000 | 9 juil. 2002 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
| US6669950 | 1 juil. 2002 | 30 déc. 2003 | Alcon, Inc. | Ophthalmic drug delivery device |
| US6699493 | 28 nov. 2001 | 2 mars 2004 | Oculex Pharmaceuticals, Inc. | Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| US6756049 | 17 déc. 2001 | 29 juin 2004 | Bausch & Lomb Incorporated | Sustained release drug delivery devices |
| US6756058 | 27 déc. 2001 | 29 juin 2004 | Bausch & Lomb Incorporated | Sustained release drug delivery devices with multiple agents |
| US6808719 | 1 juil. 2002 | 26 oct. 2004 | Alcon, Inc. | Drug delivery device |
| US6964781 | 27 déc. 2001 | 15 nov. 2005 | Bausch & Lomb Incorporated | Sustained release drug delivery devices with prefabricated permeable plugs |
| US6986900 | 5 nov. 2003 | 17 janv. 2006 | Alcon, Inc. | Ophthalmic drug delivery device |
| US6991808 | 23 janv. 2002 | 31 janv. 2006 | Bausch & Lomb Inc. | Process for the production of sustained release drug delivery devices |
| US7033605 | 22 déc. 2003 | 25 avr. 2006 | Allergan, Inc. | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| US7094226 | 12 nov. 2003 | 22 août 2006 | Alcon, Inc. | Ophthalmic drug delivery device |
| US7181287 | 24 juil. 2002 | 20 févr. 2007 | Second Sight Medical Products, Inc. | Implantable drug delivery device |
| US7527621 | 16 août 2006 | 5 mai 2009 | Second Sight Medical Products, Inc. | Implantable drug delivery device |
| US7563255 | 2 mai 2002 | 21 juil. 2009 | Massachusetts Eye and Ear Infirmary
The Charles Stark Draper Laboratory Inc. | Implantable drug delivery device and use thereof |
| US7585517 | 20 sept. 2004 | 8 sept. 2009 | Macusight, Inc. | Transscleral delivery |
| US7621907 | 11 mars 2003 | 24 nov. 2009 | Alcon, Inc. | Implantable drug delivery system |
| US7625582 | 20 avr. 2007 | 1 déc. 2009 | Allergan, Inc. | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| US7708711 | 12 nov. 2003 | 4 mai 2010 | Glaukos Corporation | Ocular implant with therapeutic agents and methods thereof |
| US7767223 | 11 juil. 2005 | 3 août 2010 | Allergan, Inc. | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use |
| US7824704 | 15 août 2005 | 2 nov. 2010 | Surmodics, Inc. | Controlled release bioactive agent delivery device |
| US7846468 | 3 nov. 2008 | 7 déc. 2010 | Allergan, Inc. | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| US7943162 | 7 déc. 2006 | 17 mai 2011 | Alcon, Inc. | Drug delivery device |
| US7976862 | 15 août 2005 | 12 juil. 2011 | Surmodics, Inc. | Controlled release bioactive agent delivery device |
| US8021680 | 29 avr. 2004 | 20 sept. 2011 | Surmodics, Inc. | Controlled release bioactive agent delivery device |
| US8034366 | 31 oct. 2007 | 11 oct. 2011 | Allergan, Inc. | Ocular implant made by a double extrusion process |
| US8034369 | 12 sept. 2005 | 11 oct. 2011 | Surmodics, Inc. | Controlled release bioactive agent delivery device |
| US8034370 | 31 oct. 2007 | 11 oct. 2011 | Allergan, Inc. | Ocular implant made by a double extrusion process |
| US8043628 | 31 oct. 2007 | 25 oct. 2011 | Allergan, Inc. | Methods for reducing edema |
| US8071120 | 30 mars 2006 | 6 déc. 2011 | Allergan, Inc. | Methods for treating neovascularization and intravitreal implants |
| US8088407 | 7 sept. 2007 | 3 janv. 2012 | Allergan, Inc. | Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| US8096972 | 19 déc. 2003 | 17 janv. 2012 | Johns Hopkins University | Devices for intraocular drug delivery |
| US8167855 | 25 août 2004 | 1 mai 2012 | Vista Scientific LLC | Ocular drug delivery device |
| US8177747 | 30 nov. 2010 | 15 mai 2012 | Alcon Research, Ltd. | Method and apparatus for drug delivery |
| US8222271 | 23 mars 2007 | 17 juil. 2012 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
| US8242099 | 12 oct. 2011 | 14 août 2012 | Allergan, Inc. | Implants and methods for treating inflammation-mediated conditions of the eye |
